The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
Open accessAbstract
Beta1- and beta2-adrenoceptors in heart muscle cells mediate the catecholamine-induced increase in the force and frequency of cardiac contraction. Recently, in addition, we demonstrated the functional expression of beta3-adrenoceptors in the human heart. Their stimulation, in marked contrast with that of beta1- and beta2-adrenoceptors, induces a decrease in contractility through presently unknown mechanisms. In the present study, we examined the role of a nitric oxide (NO) synthase pathway in mediating the beta3-adrenoceptor effect on the contractility of human endomyocardial biopsies. The negative inotropic effects of a beta3-adrenoceptor agonist, BRL 37344, and also of norepinephrine in the presence of alpha- and beta1-2-blockade were inhibited both by a nonspecific blocker of NO, methylene blue, and two NO synthase (NOS) inhibitors, L-N-monomethyl-arginine and L-nitroarginine-methyl ester. The effect of the NOS inhibitors was reversed by an excess of L-arginine, the natural substrate of NOS, but not by D-arginine. Moreover, the effects of the beta3-adrenoceptor agonist on contractility were associated with parallel increases in the production of NO and intracellular cGMP, which were also inhibited by NOS inhibitors. Immunohistochemical staining of human ventricular biopsies showed the expression of the endothelial constitutive (eNOS), but not the inducible (iNOS) isoform of NOS in both ventricular myocytes and endothelial cells. These results demonstrate that beta3-adrenoceptor stimulation decreases cardiac contractility through activation of an NOS pathway. Changes in the expression of this pathway may alter the balance between positive and negative inotropic effects of catecholamines on the heart potentially leading to myocardial dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Garthwaite, J., Charles, S. L., & Chess-Williams, R. (1988) · Nature · doi:10.1038/336385a0 · Cited by 2,549
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
Beavo, J. A. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.4.725 · Cited by 1,767
Nitric Oxide and Cardiac Function
Kelly, R. A., Balligand, J.-L., & Smith, T. W. (1996) · Circulation Research · doi:10.1161/01.res.79.3.363 · Cited by 711
Self-citationControl of cardiac muscle cell function by an endogenous nitric oxide signaling system.
Balligand, J. L., Kelly, R. A., Marsden, P. A., Smith, T. W., & Michel, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.347 · Cited by 658
Self-citationLowes, B. D., Minobe, W., Abraham, W. T., Rizeq, M. N., Bohlmeyer, T. J., Quaife, R. A., Roden, R. L., Dutcher, D. L., Robertson, A. D., Voelkel, N. F., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119770 · Cited by 503
Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes.
Méry, P. F., Lohmann, S. M., Walter, U., & Fischmeister, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1197 · Cited by 475
Méry, P. F., Pavoine, C., Belhassen, L., Pecker, F., & Fischmeister, R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74313-0 · Cited by 470
Functional beta3-adrenoceptor in the human heart.
Gauthier, C., Tavernier, G., Charpentier, F., Langin, D., & Le Marec, H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118823 · Cited by 461
Self-citationCampbell, D. L., Stamler, J. S., & Strauss, H. C. (1996) · The Journal of general physiology · doi:10.1085/jgp.108.4.277 · Cited by 441
Balligand, J. L., Ungureanu-Longrois, D., Simmons, W. W., Pimental, D., Malinski, T. A., Kapturczak, M., Taha, Z., Lowenstein, C. J., Davidoff, A. J., & Kelly, R. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47024-x · Cited by 437
Self-citationNitric oxide attenuates cardiac myocyte contraction
Brady, A. J., Warren, J. B., Poole-Wilson, P. A., Williams, T. J., & Harding, S. E. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.265.1.h176 · Cited by 408
Balligand, J.-L., Kobzik, L., Han, X., Kaye, D. M., Belhassen, L., O'Hara, D. S., Kelly, R. A., Smith, T. W., & Michel, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14582 · Cited by 388
Self-citation8-bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes.
Shah, A. M., Spurgeon, H. A., Sollott, S. J., Talo, A., & Lakatta, E. G. (1994) · Circulation Research · doi:10.1161/01.res.74.5.970 · Cited by 377
β3 and Atypical β‐Adrenoceptors
Arch, J. R. S., & Kaumann, A. J. (1993) · Medicinal Research Reviews · doi:10.1002/med.2610130604 · Cited by 312
Liggett, S. B., Freedman, N. J., Schwinn, D. A., & Lefkowitz, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3665 · Cited by 234
Hare, J. M., Loh, E., Creager, M. A., & Colucci, W. S. (1995) · Circulation · doi:10.1161/01.cir.92.8.2198 · Cited by 218
Wahler, G. M., & Dollinger, S. J. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.268.1.c45 · Cited by 216
Torres, J., Darley-Usmar, V, & Wilson, M. T. (1995) · Biochemical Journal · doi:10.1042/bj3120169 · Cited by 206
Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve.
Gross, W. L., Bak, M. I., Ingwall, J. S., Arstall, M. A., Smith, T. W., Balligand, J. L., & Kelly, R. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5604 · Cited by 200
Self-citationModulation of human cardiac function through 4 β-adrenoceptor populations
Kaumann, A. J., & Molenaar, P. (1997) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00004999 · Cited by 179
Is there a third heart β-adrenoceptor?
Kaumann, A. J. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90065-5 · Cited by 179
Hare, J. M., Keaney, J. F., Balligand, J. L., Loscalzo, J., Smith, T. W., & Colucci, W. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117664 · Cited by 174
Self-citationHan, X., Kubota, I., Féron, O., Opel, D. J., Arstall, M. A., Zhao, Y., Huang, P. L., Fishman, M. C., Michel, T. M., & Kelly, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6510 · Cited by 164
The Adenylyl Cyclases as Integrators of Transmembrane Signal Transduction
Ishikawa, Y., & Homcy, C. J. (1997) · Circulation Research · doi:10.1161/01.res.80.3.297 · Cited by 160
Bond, R. A., & Clarke, D. E. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11698.x · Cited by 150
Four β-adrenoceptor subtypes in the mammalian heart
Kaumann, A. J. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)01033-4 · Cited by 134
(—)‐CGP 12177‐induced increase of human atrial contraction through a putative third β‐adrenoceptor
Kaumann, A. J. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15159.x · Cited by 95
Malinowska, B., & Schlicker, E. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15285.x · Cited by 71
Platelet inhibition by endothelium‐derived relaxing factor from the rabbit perfused aorta
Bult, H., Fret, H. R. L., den Bossche, R. M. V., & Herman, A. G. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11769.x · Cited by 37
Cited by
The Sympathetic Nervous System in Heart Failure
Triposkiadis, F., Karayannis, G., Giamouzis, G., Skoularigis, J., Louridas, G., & Butler, J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.015 · Cited by 978
Nitric oxide signalling in cardiovascular health and disease
Farah, C., Michel, L. Y. M., & Balligand, J.-L. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.224 · Cited by 779
Self-citationAdrenergic and Muscarinic Receptors in the Human Heart
Brodde, O.-E., & Michel, M. C. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01425-x · Cited by 673
Adrenergic Nervous System in Heart Failure: Pathophysiology and Therapy
Lymperopoulos, A., Rengo, G., & Koch, W. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.300308 · Cited by 607
Nitric Oxide and Cardiac Function: Ten Years After, and Continuing
Massion, P. B., Feron, O., Dessy, C., & Balligand, J.-L. (2003) · Circulation Research · doi:10.1161/01.res.0000088351.58510.21 · Cited by 567
Self-citation
Metadata
- Authors
- Gauthier, C., Leblais, V, Kobzik, L., Trochu, J. N., Khandoudi, N., Bril, A., Balligand, J. L., & Le Marec, H.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-10-01
- Volume
- 102
- Issue
- 7
- Pages
- 1377-1384
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2090041904
- Cited by
- 397
- References
- 29
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.